Home » Media

Media

International Program Spotlights the BRICs at the 2013 BIO International Convention
With one-third of all attendees international, the 2013 BIO International Convention will host a wide range of programming focused on new opportunities...
Farmers Increasingly Favor Biotech Crops
The ISAAA report, Global Status of Commercialized Biotech/GM Crops: 2012, says a record 17.3 million farmers in 28 countries are growing biotech crops on 420...

Press Releases

Biotech Leader Provides Testimony at Congressional Hearing on ‘Spurring Job Growth through Capital Formation While Protecting Investors’
Mar 6 2012
Today, the Senate Committee on Banking, Housing, and Urban Affairs held a hearing on “Spurring Job Growth through Capital Formation While Protecting...
BIO Applauds Senator Stabenow’s Proposed Legislation Supporting Creation of a Biobased Economy
Mar 5 2012
Programs that help build a biobased economy can generate jobs and economic growth in the United States. The Biotechnology Industry Organization (BIO) today...
BIO Announces Expansion of Alliance Development Activities
Mar 2 2012
WASHINGTON, D.C. (March 2, 2012) – The Biotechnology Industry Organization (BIO) announced today that it has integrated its alliance development...
Global Leaders in Advanced Biofuels Industry Urge Congressional Leaders to Extend Critical Tax Provisions
Feb 29 2012
Leaders of America’s rapidly emerging advanced biofuels industry urged congressional leaders today to extend two tax provisions that are critical to...
Commercialization of Advanced Biofuels to be Key Theme at BIO World Congress on Industrial Biotechnology and Bioprocessing
Feb 29 2012
WASHINGTON, D.C. (Feb. 29, 2012) – Biofuel and biobased product company executives, scientists and government officials from across the globe will...
BIO Applauds Strengthening of the USDA BioPreferred Program
Feb 21 2012
The Biotechnology Industry Organization (BIO) today applauded President Obama’s directive to expand and strengthen the USDA BioPreferred program. BIO...
BIO Applauds Sen. Stabenow’s Grow It Here, Make It Here Initiative
Feb 21 2012
With strong policy direction, the United States can leverage its leadership in biotechnology, agricultural productivity and manufacturing innovation to build...
BIO Asks EPA to Reject Retroactive Changes to Renewable Fuel Standard
Feb 17 2012
A petition to retroactively change the Renewable Fuel Standard (RFS) for 2011 would undermine the industry’s progress in commercializing advanced...
BIO Plenary Speakers for the 2012 World Congress on Industrial Biotechnology and Bioprocessing to Address Advanced Biofuels, Renewable Chemicals and Creation of a Biobased Economy
Feb 16 2012
WASHINGTON, D.C. (Feb. 16, 2012) – Company executives, scientists and government officials will bring a global perspective as featured presenters at...
TREAT Act Offers Renewed Hope for Patients
Feb 15 2012
Washington, DC (February 15, 2012) – Today, the Biotechnology Industry Organization (BIO) praised Sen. Kay Hagan (D-NC) for introducing the...


Biotechnology News

Idera Announces Presentation at AAD Annual Meeting Demonstrating Toll-like Receptor Antagonists Normalize Expression of Inflammatory Genes in Psoriasis Model
March 2, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera presented new data showing that its selective Toll-like receptor antagonists normalized the gene expression of important cytokines...

Oral Apremilast Achieves Statistical Significance for the Primary Endpoint of PASI-75 in the First Phase III Study (ESTEEM 1) in Patients with Psoriasis
March 2, 2013

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today presented the results from ESTEEM 1, the Company...

KYTHERA Biopharmaceuticals, Inc. Announces Positive Interim Results from Open-Label Study of ATX-101 in the Reduction of Unwanted Submental Fat (SMF) or “Double Chin”
March 2, 2013

MIAMI BEACH, Fla.--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced positive interim results from a Phase IIIb, multi-center, open-label...

‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says the Committee on Fair Drug Pricing (a.k.a. FAIR)
March 1, 2013

SAN FRANCISCO--(BUSINESS WIRE)--‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says Committee on Fair Drug Pricing (a.k.a. FAIR)-Coalition of...

Gilead Sciences to Present at the Cowen & Company 33rd Annual Health Care Conference on Monday, March 4
March 1, 2013

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the Cowen and Company 33rd...